Cross Country Healthcare downgraded to Hold from Buy at Cantor Cantor downgraded Cross Country Healthcare citing valuation following the company's Q4 results. The firm has a $6 price target for shares.
News For CCRN From The Last 14 Days
Check below for free stories on CCRN the last two weeks.